Concepedia

Qin Sun

QS

Statistics

Publications

5

Citations

56

H-Index

5

Active since

2022

Affiliations

Center for Drug Evaluation and Research(Current)

Spaulding Clinical Research (United States)

United States Food and Drug Administration

Booz Allen Hamilton (United States)

Qin Sun is an author at Center for Drug Evaluation and Research specializing in biomarker-based efficacy assessment, biomarker development, and pharmacy.

ORCID

Publications per year

2022–2025

5

Publications

5

IFN-γ-mediated inhibition of JAK/STAT signaling via nano-scutellarin treatment is an efficient strategy for ameliorating liver fibrosis

Bangguo Liu, Juan Huang, Qixin Zhao et al. · Journal of Translational Medicine · 2025 · 13 citations · Full text

, , +17

Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (<scp>III</scp>) A Randomized Trial with Interferon Beta‐1a Products

Jeffry Florian, Victoria Gershuny, Qin Sun et al. · Clinical Pharmacology & Therapeutics · 2022 · 12 citations

, , +16

Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of <scp>IFNβ</scp>‐1a Biologics

Paula L. Hyland, Lakshmi Manasa S. Chekka, Deepti P. Samarth et al. · Clinical Pharmacology & Therapeutics · 2022 · 11 citations

, , +17

Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (II) A Randomized Trial with IL‐5 Antagonists

Victoria Gershuny, Qin Sun, Sarah J. Schrieber et al. · Clinical Pharmacology & Therapeutics · 2022 · 10 citations

, , +16

Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (I) A Randomized Trial with <scp>PCSK9</scp> Inhibitors

Morasa Sheikhy, Sarah J. Schrieber, Qin Sun et al. · Clinical Pharmacology & Therapeutics · 2022 · 10 citations

, , +16

1–5 of 5